RecruitingNot ApplicableNCT02811653
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrollment
155 participants
Start Date
Dec 16, 2015
Study Type
INTERVENTIONAL
Conditions
Summary
In AD (Alzheimer disease), the anatomic correlates of attention disorders (as evaluated by motor slowing) have not been thoroughly characterized.
Eligibility
Min Age: 40 YearsMax Age: 85 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a biological treatment called Blood, a medical device called Brain MRI, and others for people with alzheimer disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 85 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEBrain MRI
OTHERneuropsychological evaluation
BIOLOGICALBlood
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02811653
Related Trials
Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers
NCT0772170112 locations
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
NCT071589055 locations
Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
NCT077207651 location
A Study of LY3439539 in Participants With Alzheimer's Disease
NCT075983709 locations
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
NCT076334705 locations